Beta-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk

R K Ganju1, S A Brubaker, R D Chernock

  • 1Division of Experimental Medicine, Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, USA. rganju@caregroup.harvard.edu

Insights

The beta-chemokine receptor CCR5, a target for HIV, activates signaling pathways involving RAFTK and Syk kinases. This study identifies a signaling complex including RAFTK, Syk, SHP1, and Grb2, crucial for MIP1beta-induced cell migration.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Signaling

Background:

  • The beta-chemokine receptor CCR5 plays a role in cell migration, proliferation, and immune responses.
  • CCR5 also functions as a co-receptor for the human immunodeficiency virus (HIV).
  • Previous research indicated CCR5 activates related adhesion focal tyrosine kinase (RAFTK)/Pyk2/CAK-beta.

Purpose of the Study:

  • To further characterize signaling molecules activated by CCR5 upon binding to its ligand, macrophage inflammatory protein-1beta (MIP1beta).
  • To elucidate the roles of phosphatases SHP1 and SHP2, and the kinase Syk in CCR5-mediated signaling.
  • To determine the upstream or downstream relationship between RAFTK and Syk in this pathway.

Main Methods:

  • Stimulation of CCR5-expressing cells (L1.2 transfectants and T-cells) with MIP1beta.
  • Analysis of tyrosine phosphorylation of SHP1 and SHP2.
  • Co-immunoprecipitation assays to study protein-protein interactions (SHP1-RAFTK, SHP1/SHP2-Grb2-Syk, Syk-RAFTK).
  • Use of dominant-negative mutants of RAFTK (RAFTK(m906), RAFTK(m402)) and phosphatase inhibitor (orthovanadate).
  • Assessment of MIP1beta-induced chemotaxis.

Main Results:

  • MIP1beta stimulation enhanced tyrosine phosphorylation of SHP1 and SHP2 in CCR5-expressing cells.
  • SHP1 associated with RAFTK, but RAFTK did not mediate SHP1/SHP2 phosphorylation.
  • SHP1 and SHP2 associated with Grb2 and Syk; Syk was activated by MIP1beta and associated with RAFTK.
  • Dominant-negative RAFTK mutants attenuated Syk activation, while wild-type RAFTK enhanced it, indicating RAFTK acts upstream of Syk.
  • Orthovanadate pretreatment abolished MIP1beta-induced chemotaxis.

Conclusions:

  • MIP1beta stimulation of CCR5 leads to the activation of phosphatases SHP1 and SHP2.
  • The signaling pathway involves the formation of a complex including RAFTK, Syk, SHP1, and Grb2.
  • RAFTK acts upstream of CCR5-mediated Syk activation, playing a key role in MIP1beta-induced cell migration.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...